METABOLISM OF LPA-I AND LPA-I--A-II IN HUMANS
LPA-I 和 LPA-I--A-II 在人体中的代谢
基本信息
- 批准号:3757637
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
HDL are heterogeneous and the major lipoprotein particles include LpA-
I,and LpA-I:A-II. Current data based on epidemiological, cell culture,
as well as transgenic animal studies are consistent with LpA-I being the
antiatherogenic particle within HDL. In our previous studies we have
established that LpA-I is catabolized at a faster rate than LpA-I:A-II.
LpA-I:A-II is fromed by the addition of apoA-II to LpA-I particles.
Three subclasses of LpA-I are present in human plasma. These three
subclasses designated Large, Medium, and Small have different lipid and
apolipoprotein composition as well as concentrations of CETP and LCAT
activities indicating the important heterogeneity of the LpA-I particles.
Women have a higher plasma concentration than men of only the Large LpA-I
particle with similar concentration of the Middle and Small LpA-I
particles. The metabolism of the three LpA-I particles was investigated
in normal control subjects. The catabolism of the Small LpA-I was the
fastest of the three LpA-I particles clearly establishing that the
catabolism of LpA-I is critically dependent on the size of the LpA-I
particle.
To gain insight into the metabolism of LpA-I and LpA-I:A-II kinetic
studies were performed in fifty normolipidemic subjects and the
associations with lipids and apolipoprotein levels determined.
Triglyceride levels inversely correlated with only LpA-I. ApoA-I levels
were most strongly correlated with the catabolic rate. ApoA-II levels
were only correlated with synthesis rate. Plasma LpA-I levels are
correlated with the catabolism of both apoA-I and apoA-II while LpA-I:A-
II levels were correlated with the synthesis rates of apoA-I and apoA-II.
Based on multiple regression analysis the production rate of apoA-II is
the only independent kinetic parameter determining the plasma LpA-I
levels. Further studies are underway to investigate additional
parameters that modulate LpA-I and LpA-I:A-II metabolism.
These studies included subjects of age 19 to 47. 52% of the study
subjects were women, seven were Asian, and three were Indian.
HDL是异质性的,主要的脂蛋白颗粒包括LpA-
I和LpA-I:A-II。 基于流行病学,细胞培养,
以及转基因动物研究与LpA-I是
HDL中的抗动脉粥样硬化颗粒。 在我们以前的研究中,
确定LpA-I以比LpA-I:A-II更快的速率分解代谢。
LpA-I:A-II是通过将apoA-II添加到LpA-I颗粒中形成的。
人血浆中存在LpA-I的三个亚类。 这三
指定为大型、中型和小型的子类具有不同的脂质和
载脂蛋白组成以及CETP和LCAT浓度
活性表明LpA-I颗粒的重要异质性。
女性仅大LpA-I的血浆浓度高于男性
中等和小LpA-I浓度相似的颗粒
粒子 研究了三种LpA-I颗粒的代谢
在正常对照组中。 小LpA-I的目录是
最快的三个LpA-I粒子清楚地表明,
LpA-I的催化活性严重依赖于LpA-I的大小,
粒子
了解LpA-I和LpA-I:A-II的代谢动力学
在50名血脂正常的受试者中进行了研究,
与血脂和载脂蛋白水平的关系。
甘油三酯水平仅与LpA-I呈负相关。ApoA-I水平
与分解代谢率相关性最强。ApoA-II水平
仅与合成速率相关。 血浆LpA-I水平是
与apoA-I和apoA-II的催化活性相关,而LpA-I:A-
II水平与apoA-I和apoA-II的合成速率相关。
根据多元回归分析,apoA-II的产生率为
决定血浆LpA-I的唯一独立动力学参数
程度. 正在进行进一步的研究,
调节LpA-I和LpA-I:A-II代谢的参数。
这些研究包括19至47岁的受试者。52%的研究
受试者为女性,7名亚洲人,3名印度人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D J RADER其他文献
D J RADER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D J RADER', 18)}}的其他基金
APOLIPOPROTEIN METABOLISM IN CETP DEFICIENCY AND HYPERALPHALIPOPROTEINEMIA
CETP 缺乏和高α脂蛋白血症中的载脂蛋白代谢
- 批准号:
3843306 - 财政年份:
- 资助金额:
-- - 项目类别:
APOLIPOPROTEIN METABOLISM IN CETP DEFICIENCY AND HYPERALPHALIPOPROTEINEMIA
CETP 缺乏和高α脂蛋白血症中的载脂蛋白代谢
- 批准号:
3858033 - 财政年份:
- 资助金额:
-- - 项目类别:
APOLIPOPROTEIN METABOLISM IN CETP DEFICIENCY AND HYPERALPHALIPOPROTEINEMIA
CETP 缺乏和高α脂蛋白血症中的载脂蛋白代谢
- 批准号:
3779545 - 财政年份:
- 资助金额:
-- - 项目类别:
METABOLISM OF HDL APOLIPOPROTEINS IN NORMAL & HYPOALPHALIPOPROTEINEMIC SUBJECTS
正常情况下 HDL 载脂蛋白的代谢
- 批准号:
3779541 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Advanced non-invasive optical measurement techniques for the constant monitoring of blood lipid components
先进的无创光学测量技术,持续监测血脂成分
- 批准号:
23K11799 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
BlindSite: Blood, Lipid and Illicit Narcotics Detection and Situation
BlindSite:血液、脂质和非法麻醉品检测和情况
- 批准号:
10004475 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Collaborative R&D
Non-invasive prediction of blood lipid concentrations by mid-infrared attenuated total reflection measurement on the body surface
体表中红外衰减全反射测量无创预测血脂浓度
- 批准号:
20K12615 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Introduction of standing desk in the class room and blood lipid profile in children
教室站立课桌介绍及儿童血脂监测
- 批准号:
18K17901 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
EARLY DETECTION OF DIABETIC RETINOPATHY BY PERIPHERAL BLOOD LIPID PROFILING
通过外周血脂分析早期检测糖尿病视网膜病变
- 批准号:
9197299 - 财政年份:2016
- 资助金额:
-- - 项目类别:
EARLY DETECTION OF DIABETIC RETINOPATHY BY PERIPHERAL BLOOD LIPID PROFILING
通过外周血脂分析早期检测糖尿病视网膜病变
- 批准号:
9033384 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Genetic anthropology of the blood lipid level
血脂水平的遗传人类学
- 批准号:
21687021 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Young Scientists (A)
Development of blood lipid biomarkers for Alzheimer's disease progression
开发阿尔茨海默病进展的血脂生物标志物
- 批准号:
7491658 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Development of blood lipid biomarkers for Alzheimer's disease progression
开发阿尔茨海默病进展的血脂生物标志物
- 批准号:
7305882 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Research of Novel Mechanism in the Genesis of Diabetes Mellitus: The Dysfunction of pancreatic beta cell by the Increase of Blood Lipid Peroxides
糖尿病发病新机制研究:血脂过氧化物升高导致胰岛β细胞功能障碍
- 批准号:
13671202 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)